Anastrozole / Arimidex Somatrop-Lab
- Brand: Somatrop-Lab
- Availability: In Stock
- €30.00 €29.00
- Ex Tax: €29.00
Alternative product names: Anastrozole, Anast, Arimidex, Aremed
Available in warehouses:: Warehouse EU-1 (HB/SL)
Anastrozole, known under the brand name Arimidex by Somatrop-Lab, is a leading aromatase inhibitor. It is primarily utilized for treating hormone receptor-positive breast cancer in postmenopausal women. By effectively reducing estrogen production in the body, it helps in slowing or stopping the growth of estrogen-dependent tumors. With rigorous production standards, Somatrop-Lab ensures that their product is a trusted choice for both medical treatments and performance enhancement.
Primary Effects
The primary effects include:
- Substantial reduction in estrogen levels.
- Slowing or halting the growth of estrogen-dependent tumors.
- Mitigation of estrogen-related side effects in men using anabolic steroids.
Additional Benefits
Additional benefits include:
- Enhanced testosterone levels due to lower estrogen.
- Decreased water retention and bloating often associated with high estrogen levels.
- Improved muscle definition and hardness for athletes and bodybuilders.
How to Use
This medication is typically administered orally. For managing estrogen-related side effects in men, the recommended dosage is 0.5 mg to 1 mg per day. For breast cancer treatment, the standard dose is 1 mg per day. Following the prescribed dosage and consulting with a healthcare professional for personalized advice is essential.
Administration Tips
- Take the medication at the same time each day to maintain consistent blood levels.
- It can be taken with or without food.
- Do not double the dose if a dose is missed; take the next dose as scheduled.
- Regular blood tests are recommended to monitor estrogen levels and adjust the dosage if necessary.
Why Choose Somatrop-Lab's Product?
Opting for this product from Somatrop-Lab provides:
- High purity and potency ensured by stringent manufacturing processes.
- Reliable quality from a reputable pharmaceutical company.
- Effective management of estrogen levels for both medical and performance-enhancing purposes.
Combining with Other Compounds
This medication can be effectively combined with:
- Testosterone: To manage estrogen levels and prevent gynecomastia during testosterone replacement therapy or anabolic steroid cycles.
- Tamoxifen (Nolvadex): For a more comprehensive approach to estrogen control and the treatment of hormone receptor-positive breast cancer.
For Post-Cycle Therapy (PCT)
For PCT, it can be combined with:
- Clomiphene Citrate (Clomid): To help restore natural testosterone production and maintain hormonal balance after a steroid cycle.
- HCG (Human Chorionic Gonadotropin): To stimulate endogenous testosterone production and preserve muscle gains.
For Estrogen Management
For estrogen management, it can be combined with:
- Letrozole: For a more aggressive approach to lowering estrogen levels in severe cases.
- Proviron (Mesterolone): To enhance androgen levels while controlling estrogen.
For Overall Hormonal Balance
For overall hormonal balance, it can be combined with:
- Dehydroepiandrosterone (DHEA): To support adrenal function and overall hormonal health.
- Vitamin D3: To support overall health and hormonal function.
Conclusion
This medication from Somatrop-Lab offers a reliable solution for managing estrogen levels in both medical and performance-enhancing contexts. Its high-quality formulation ensures effective reduction of estrogen-related issues, making it a valuable addition to hormone receptor-positive breast cancer treatment and anabolic steroid cycles. By choosing this product from Somatrop-Lab, users can expect trusted results and improved hormonal balance.
Characteristics | |
Drug Class | Aromatase Inhibitor |
Concentration | Typically 1 mg per tablet |
Half-Life | Approximately 46 hours |
Detection Time | Not typically tested in standard drug screenings |
Form | Oral tablets |
Progestational Activity | None |
Liver Toxicity | Low |
Chemical Structure | C17H19N5 |
Estrogenic Activity | Antagonist |